Fig. 2: TP53 heterogeneous immunophenotype in invasive vulvar squamous cell carcinoma.

a Primary tumor H&E; b lymph node metastasis (synchronous with primary tumor) H&E; c 1st recurrence H&E; d positive TP53 in primary tumor; e negative TP53 in lymph node metastasis; f positive TP53 in 1st recurrence.